An Epstein-Barr virus-encoded protein, ZEBRA, mediats the switch from latency to the viral lytic life cycle. ZEBRA's domain structure and DNA binding specificity resemble that of ceflular trnscriptional activators such as c-Fos/c-Jun. We show that ZEBRA, like c-Jun, is phosphorylated by casein kinase II (CKII). The principal site of phosphorylation is serine-173 (S173), five amino adds upstream of the basic DNA recognition domain. CKII phosphorylation abrogated ZEBRA's capacity to bind its target DNA sequences.
abrogated ZEBRA's capacity to bind its target DNA sequences. S173 is a functional component of ZEBRA's DNA binding domain, since mutation of S173 to alanine (S173A) reduced DNA binding in vitro to 10% of wild-type levels. Transcriptional activation of a native viral promoter in vivo by mutant S173A was also reduced markedly. Reversible phosphorylation of S173 is likely to be an important means of regulating ZEBRA's activity in vivo.
Epstein-Barr virus (EBV) can be switched from latency into the viral lytic cycle by expression of a virally encoded protein, ZEBRA (1, 2) . ZEBRA binds DNA and activates transcription from promoters of early viral lytic cycle genes (3, 4) . Several other proteins that regulate EBV gene expression are encoded among these early lytic cycle genes (5, 6) . The C terminus of ZEBRA encodes a DNA binding domain composed of basic amino acids (basic domain) followed by a protein homodimerization domain. This organization is similar to the basic zipper (bZIP) motif found in many transcriptional activators (7) (8) (9) (Fig. 1A) . ZEBRA is homologous to bZIP proteins of the c-Fos/c-Jun family in the basic DNA recognition domain. Furthermore, ZEBRA and c-Fos/c-Jun share the ability to bind a heptamer AP-1 consensus site (10) . ZEBRA also binds other heptamer DNA sequences (ZEBRA response elements; ZREs) not bound by c-Fos/c-Jun (4, [15] [16] [17] .
Cellular kinases such as casein kinase II (CKII) regulate the activity of many nuclear DNA binding proteins (18) (19) (20) (21) . CKII, a ubiquitous protein kinase present in both the cytoplasm and nucleus of eukaryotic cells, catalyzes the phosphorylation of serine or threonine residues N-terminal to clusters of acidic amino acids (22, 23) . Although CKII activity can be detected in resting cells, it is elevated in cells treated with mitogens (24) (25) (26) (27, 28 are both phosphorylated by CKII (12, 29) (Fig. 1B) . Phosphorylated Max homodimers fail to bind DNA in vitro; however, phosphorylated Myc/Max heterodimers do bind DNA (13) . c-Jun can be phosphorylated by CKII, although the effect of this modification on DNA binding is not clear (11, 30) . In addition to DNA binding, other properties of transcription factors such as nuclear localization, transactivation, or transrepression are influenced by phosphorylation by CKII (21) .
We determined whether the activity of ZEBRA, a viral immediate early transcriptional activator, is influenced by phosphorylation. We found that phosphorylation of ZEBRA by CKII inhibited DNA binding. ZEBRA contains two potential CKII acceptor sites, serine-167 and -173 (S167 and S173), in an acidic domain N-terminal to the basic DNA recognition domain (10) (Fig. 1B) . By examining proteins mutated at these potential acceptor sites for their ability to be phosphorylated by CKII in vitro, we mapped the principal phosphorylation site to S173. We found that ZEBRA mutants in which S173 was mutated to alanine (S173A) were markedly inhibited in their ability to bind DNA and to activate transcription of a ZEBRA-inducible viral early gene.
METHODS AND MATERIALS
Plasmids. Plasmid constructs expressing full-length or deleted ZEBRA as TrpE fusion proteins in Escherichia coli have been described (17, 31) . ZEBRA mutants S167A and S173A were constructed by PCR-based mutagenesis (32) . To make S167A, the oligonucleotide 5'-GAATCGCATTCCTC-CAGCG(CTTCTGG-3' (single point mutation underlined) and an oligonucleotide in vector sequences were used to prime the wild-type ZEBRA cDNA. The reaction product was cut at both ends with Bsm I and ligated to a Bsm I cut TrpE-ZEBRA expression construct. Similarly, the mutant S173A was constructed by using 5'-TATTTCTAGTTCAG-CATCGC-3', cutting the PCR product and the TrpE-ZEBRA expression construct with Nhe I and Rma I and ligating. ZEBRA S167A/S173A was constructed by swapping the Bsm I fragment from ZEBRA S167A into ZEBRA S173A. ZEBRA M187-189 has basic amino acids RKC in the DNA recognition domain replaced with EES (17) . ZEBRA coding sequences were transferred by using convenient polylinker restriction sites to the pSP64 or pSP65 expression vectors for in vitro transcription and to the cytomegalovirus virus eukaryotic expression vector pHD1013 for use in B-cell transfections (33 (17) . The mutant proteins Z(141-245), Z(1-110 + 160-245), and Z were all phosphorylated (data not shown). This analysis localized the region recognized by CKII to amino acids 160-198. There are three serines in this region: S167, S173, and S186 (Fig.  1B) . However, S186 is in the center ofthe basic DNA binding domain and is not associated with the previously described CKII consensus sequences (22) .
The principal target for CKII phosphorylation was determined by examining ZEBRA proteins mutated at S167 and S173. The serines at positions 167 and 173 were changed to alanines singly (ZEBRA S167A, ZEBRA S173A) and together (ZEBRA S167A/S173A) (Fig. 2) . Fig. 2A shows that full-length ZEBRA and the ZEBRA S167A mutant were strongly phosphorylated, whereas ZEBRA S173A and the double mutant were weakly labeled. Therefore, the primary site of ZEBRA phosphorylated by CKII is S173. The low level ofphosphorylation ofZEBRA S173A suggests that S167 may be a secondary target for CKII. (Fig. 2A, lane 8) . Cross-linking of in vitro translated proteins indicated that all the ZEBRA mutants dimerized in solution except Z(1-198) (Fig. 2B) . Thus, sequences in the basic domain but not in the dimerization region are required for CKII phosphorylation.
CKU Phosphorylation Inhibits Specific DNA Binding by ZEBRA. Purified ZEBRA protein or E. coli extract containing TrpE-ZEBRA fusion protein were preincubated with CKII and ATP before binding to a 32P-labeled oligonucleotide containing a ZRE and analyzed by EMSA. Equivalent results were obtained with both expressed forms of ZEBRA (Fig. 3) alone (Fig. 3, lanes 1-3) . However, binding to the AP-1 oligonucleotide was almost completely inhibited when the ZEBRA proteins were preincubated with both ATP and CKII (lanes 4). Similar results were obtained with an oligonucleotide containing a ZIIIB site (data not shown).
The inhibition of ZEBRA's ability to bind DNA after CKII phosphorylation was reversible. Both preparations ofZEBRA that had been phosphorylated by CKII were treated with PP2A and then analyzed for DNA binding activity (37) . PP2A treatment partially restored DNA binding activity (lanes 5).
ZEBRA Mutation S173A Markedly Reduces DNA Binding Affinity in Vitro. E. coli extracts containing equal amounts of wild-type or serine point-mutant TrpE-ZEBRA fusion proteins were tested for DNA binding activity. In Fig. 4 10) . Mutants S173A and S167A/S173A were markedly reduced in their capacity to bind both probes, to -10% of wild-type levels (lanes 4, 5, 11, and 12). Only trace binding activity was measured with the mutants, which alter the basic domain (M187-189) or delete the dimerization domain [Z( ]. The five ZEBRA mutants showed the same relative reduced affinity for all ZREs tested (data not shown).
Serine Point Mutants of ZEBRA Have Reduced Transactivation Activity in Vivo. The effect of S173 and S167 mutations on the capacity of ZEBRA to activate transcription in vivo was tested in two assays. In the first assay, wild-type or mutant ZEBRA expression constructs were examined for their ability to activate a cotransfected reporter plasmid in EBV-negative human B cells (BJAB). The reporter contained the promoter of a ZEBRA-responsive early lytic cycle gene, BMRF1, linked to CAT (35) . In the second assay, we studied the ability of wild-type and mutant ZEBRA proteins to activate transcription of the BMRF1 gene from the latent EBV genome in Raji cells. Using reporter gene assays, mutant S167A was -33% as active as wild-type ZEBRA, whereas S173A was -11% as active as wild type (averages of data from Fig. SA ; data not shown). Increasing the amount of activator plasmid in the cotransfection assay compensated for the mutant phenotypes. Mutants S167A and S173A were, respectively, 22% and 4% as active as wild type in stimulating transcription of BMRF1 from the latent genome in Raji cells (Fig. SB) . In both assays the double-mutant S167A/S173A, although severely impaired relative to wild type, was more active than the single S173A mutant. All three mutants and wild-type ZEBRA partitioned to the nucleus to the same extent (data not shown). Phosphorylation of S173 may disrupt DNA binding and, therefore, transactivation by shifting ZEBRA into a conformation that restricts DNA binding. ZEBRA differs from Oct-1 and SRF, whose DNA binding activities are also regulated by CKII phosphorylation (41, 42) . Serine-toalanine substitutions in the phosphorylation sites ofOct-1 and SRF do not impair their capacity to bind DNA.
DISCUSSION
The decreased ability of ZEBRA mutant S173A to activate transcription of an EBV early gene in vivo correlated with its impaired capacity to bind DNA. ZEBRA S167A was also affected in its capacity to bind DNA and activate transcription although to a lesser extent than ZEBRA S173A. Compared to mutant S173A, the double-mutant S167A/S173A was more active in vivo, even though it was as deficient as S173A in DNA binding. These results suggest that mutations of S167 and S173 may affect some property of ZEBRA other than DNA binding. One explanation for these observations is that ZEBRA may contact other proteins in order to activate transcription and disrupt latency. Modification of either S167 or S173 may alter the three-dimensional structure of the ZEBRA protein in a region that contacts the ancillary factor. Alternatively, mutation or phosphorylation of S167 or S173 may influence the stability and half-life of the ZEBRA protein.
Analogy Between ZEBRA and CeUlular Immediate Early Genes. Stimulation of quiescent cells, in the absence of de novo protein synthesis, is accompanied by transcription of cellular early response or immediate early genes. Among these genes are nuclear proteins, such as c-Myc, c-Fos, and c-Jun, which are believed to play a role in regulating subsequent events in the cell cycle (18) . ZEBRA has several features in common with the cellular immediate early genes. Its transcription is activated by external stimuli in the absence of protein synthesis (43, 44) and may be regulated by SRF, a DNA binding protein that modulates c-Fos transcription (45) . Also, the DNA binding specificity of ZEBRA overlaps that of c-Fos/c-Jun (4, (15) (16) (17) .
Our study demonstrates that ZEBRA, like cellular immediate early genes, has functional CKII phosphorylation sites N-terminal to its DNA binding domain. Moreover, CKII phosphorylation of ZEBRA inhibits DNA binding. The general structure N-terminal kinase site/DNA binding domain (kbZIP) appears to be a conserved motifby which the activity of a DNA binding protein can be modulated by kinases and phosphatases in response to mitogenic and other external stimuli. The biologic role of ZEBRA as an immediate early gene in the EBV lytic life cycle may be analogous to immediate early genes that initiate the cell cycle. The virus may respond to external stimuli and changes in patterns of cell growth via changes in the phosphorylation state of ZEBRA.
